Group 1 - Sandisk Corporation (SNDK) shares have increased by 17.3% in the past four weeks, closing at $195.96, with a mean price target of $262.54 indicating a potential upside of 34% [1] - The average of 13 short-term price targets ranges from a low of $220.00 to a high of $300.00, with a standard deviation of $23.85, suggesting a potential increase of 12.3% to 53.1% from the current price [2] - Analysts show strong agreement on SNDK's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 75.9% over the past month, with five estimates increasing and no negative revisions [12] - SNDK holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which appears to be a good guide [14]

Group 1 - O-I Glass (OI) closed at $12.7, with a 3.3% gain over the past four weeks, and a mean price target of $16.56 suggests a 30.4% upside potential [1] - The average price targets range from $13.00 to $19.00, with a standard deviation of $2.07, indicating variability among analysts' estimates [2] - Analysts have shown increasing optimism about OI's earnings prospects, with a strong agreement in revising EPS estimates higher, correlating with potential stock price movements [11][12] Group 2 - The Zacks Consensus Estimate for the current year has increased by 8.3% over the past month, with four estimates going higher and no negative revisions [12] - OI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - El Pollo Loco Holdings (LOCO) has seen a 7.1% increase in share price over the past four weeks, closing at $10.24, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $13.67, representing a 33.5% upside [1][2]. Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $3.79, where the lowest estimate of $11.00 indicates a 7.4% increase, and the highest estimate of $18.00 suggests a 75.8% increase [2]. - A low standard deviation among price targets indicates a strong agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases, as indicated by a 6.7% increase in the Zacks Consensus Estimate over the past month [11][12]. - LOCO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, the implied direction of price movement appears to be a valid guide for investors [14].

Core Viewpoint - Super Group (SGHC) Limited has shown a recent price increase and analysts suggest significant upside potential based on price targets, with a mean target indicating a 48.8% increase from the current price [1][2]. Price Targets and Analyst Estimates - The mean price target for SGHC is $18, with a standard deviation of $1.2 across eight estimates, indicating a consensus among analysts [2]. - The lowest estimate is $16.00, suggesting a 32.2% increase, while the highest estimate is $20.00, indicating a potential surge of 65.3% [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about SGHC's earnings prospects, with a positive trend in earnings estimate revisions [11]. - Over the past 30 days, one estimate has increased, leading to an 8.7% rise in the Zacks Consensus Estimate for the current year [12]. - SGHC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, and reliance solely on them may not yield favorable returns [7][10]. - Analysts may set optimistic price targets due to business incentives, which can inflate expectations [8].

Core Viewpoint - Boston Scientific (BSX) shows potential for upside with a mean price target of $127.55, indicating a 25.3% increase from the current price of $101.76 [1] Price Targets and Estimates - The mean estimate consists of 31 short-term price targets with a standard deviation of $6.38, suggesting a consensus among analysts [2] - The lowest estimate is $113.00, indicating an 11.1% increase, while the highest estimate is $140.00, suggesting a 37.6% increase [2] - Analysts' price targets can be misleading, as they may not accurately reflect the stock's future price movements [7][10] Earnings Estimates - Analysts are optimistic about BSX's earnings prospects, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [11] - In the last 30 days, 11 estimates have been revised upward, leading to a 2% increase in the Zacks Consensus Estimate [12] Zacks Rank - BSX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - This rank serves as a more conclusive indicator of the stock's potential upside in the near term [13] Conclusion on Price Movement - While the consensus price target may not be a reliable measure of potential gains, it does provide a directional guide for price movement [14]

Group 1 - Business First (BFST) shares have increased by 4.7% over the past four weeks, closing at $24.25, with a mean price target of $30.9 indicating a potential upside of 27.4% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $0.74, where the lowest estimate suggests a 23.7% increase and the highest predicts a 32% surge to $32.00 [2] - Analysts show strong agreement on BFST's ability to report better earnings, with a positive trend in earnings estimate revisions, which is a strong indicator of potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for BFST has increased by 1.3% due to two upward revisions in earnings estimates over the last 30 days, with no negative revisions [12] - BFST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for price movement direction [14]

Core Viewpoint - Mirion Technologies, Inc. (MIR) has seen a 3.1% increase in share price over the past four weeks, closing at $24.91, with analysts suggesting a potential upside based on price targets averaging $31.83, indicating a 27.8% increase from the current price [1] Price Targets - The average price target consists of six estimates ranging from a low of $29.00 to a high of $35.00, with a standard deviation of $2.79, suggesting a consensus among analysts [2] - The lowest estimate indicates a 16.4% increase, while the highest suggests a 40.5% upside, highlighting the variability in analyst predictions [2] Analyst Sentiment - There is strong agreement among analysts regarding MIR's ability to exceed previous earnings estimates, which supports the potential for stock price appreciation [4][11] - Recent revisions in earnings estimates show two upward adjustments and one downward, resulting in a 3.9% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank - MIR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a definitive indicator of MIR's potential gains, the direction implied by these targets appears to be a useful guide for investors [14]

Group 1 - Q2 Holdings (QTWO) closed at $71.72, with a 21% gain over the past four weeks, and a mean price target of $92 suggests a 28.3% upside potential [1] - The average of 14 short-term price targets ranges from $74.00 to $110.00, with a standard deviation of $11.37, indicating variability in analyst estimates [2] - Analysts show strong agreement that QTWO will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for QTWO's current year earnings has increased by 17.4% over the past month, with five estimates revised upward and no negative revisions [12] - QTWO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of QTWO's gains, they do provide a directional guide for price movement [14]

Core Viewpoint - MBX Biosciences, Inc. (MBX) has shown significant stock price appreciation of 74.8% over the past four weeks, with a mean price target of $58.25 indicating a potential upside of 142% from the current price of $24.07 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $16.63, suggesting variability in analyst predictions. The lowest estimate is $30.00, indicating a 24.6% increase, while the highest estimate is $80.00, suggesting a 232.4% increase [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Consensus - Analysts have shown increasing optimism regarding MBX's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 2.7% over the past month, with three estimates increasing and no negative revisions [12] - MBX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Caution on Price Targets - While consensus price targets are often sought after, they can mislead investors, as empirical research shows that they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should approach price targets with skepticism and not rely solely on them for investment decisions [10][14]

Core Viewpoint - The Beachbody Company, Inc. (BODI) shows potential for significant upside, with a mean price target of $10.75 indicating an 82.5% increase from its current price of $5.89 [1] Price Targets and Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $3.88, suggesting variability among analysts [2] - The lowest estimate of $6.50 indicates a 10.4% increase, while the highest estimate of $15.50 suggests a potential surge of 163.2% [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts show growing optimism about BODI's earnings prospects, as indicated by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 20.3%, with one estimate moving higher and no negative revisions [12] - BODI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, and reliance solely on them may lead to poor investment decisions [3][7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]